Gal-3 silencing reduced invasiveness and inhibited VM formation in melanoma through down-regulation of the expression of some endothelial markers, such as VE-cadherin, together with the release of interleukin-8 (IL-8) was found to decrease. This evidence concerns the gene CXCL8 and melanoma.